SELECTED BURTON PUBLICATIONS

Wang, S-K., P-H. Liang, R.D. Astronomo, T-L. Hsu, S-L. Hsieh, D.R. Burton , C-H. Wong .   Targeting the carbohydrates on HIV-1: interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN.    Proc. Natl. Acad. Sci. USA , 105 :3690-3695, 2008. [PubMed Abstract]

Bell, C.H., R. Pantophlet, A. Schiefner, L.A. Cavacini, R.L. Stanfield, D.R. Burton, I.A. Wilson.   Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization.   J. Mol. Biol ., 375 :969-78 , 2008. [PubMed Abstract]

Astronomo, R.D., H-K. Lee, C.N. Scanlan, R. Pantophlet, C-Y Huang, I.A. Wilson, O. Blixt, R.A. Dwek, C-H. Wong, D.R. Burton .   A glycoconjugate antigen, based on the recognition motif of a broadly-neutralizing HIV antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the 'self' glycans of gp120 . J. Virol., e-pub ahead of print, April 23, 2008. [PubMed Abstract]

Hedestam, G.B.K., R.A.M. Fouchier, S. Phogat, D.R. Burton , J. Sodroski, R.T. Wyatt.   The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus.   Nature Rev. Microbiol., 6: 143-155, 2008. [PubMed Abstract]

Scanlan, C.N., D.R. Burton , R.A. Dwek, Making autoantibodies safe.   Proc. Natl. Acad. Sci. USA , 105 :4081-4082, 2008. [PubMed Abstract]

Walker, B.D., D.R. Burton .   Towards an AIDS vaccine.   Science, 320: , 2008. [PubMed Abstract]

Zhou, T., L. Xu, B. Dey, A.J. Hessell, D. Van Ryk, S-H. Xiang, X. Yang, M-Y. Zhang, M.B. Zwick, J. Arthos, D.R. Burton , D.S. Dimitrov, J. Sodroski, R. Wyatt, G.J. Nabel, P. D. Kwong.   Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature, 445 :732-737, 2007. [PubMed Abstract]

Nelson, J.D., F.M. Brunel, R. Jensen, E.T. Crooks, R.M.F. Cardoso, M. Wang, A. Hessell, I.A. Wilson, J.M. Binley, P.E. Dawson, D.R. Burton , M.B. Zwick.   In vitro affinity maturation of Z13, a broadly neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) gp41. J. Virol. 81:4033-4043, 2007. [PubMed Abstract]

Pantophlet, R., R.O. Aguilar-Sino, T. Wrin, L.A. Cavacini, D.R. Burton . Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis. Virology, 364: 441-453, 2007. [PubMed Abstract]

Dhillon, A.K., H. Donners, R. Pantophlet, W.E. Johnson, J.M. Decker, G.M. Shaw, F-H. Lee, D.D. Richman, R.W. Doms, G. Vanham, D.R. Burton .   Dissecting the neutralizing antibody specificities of broadly neutralizing sera from HIV-1 infected donors. J. Virol. , 81: 6548-6562, 2007. [PubMed Abstract]

Crooks, E.T., P.L. Moore, M. Franti, C.S. Cayanan, P. Zhu, P. Jiang, R. deVries, C. Wiley, I. Zharkikh, N. Sch ülke, K.H. Roux, D.C. Montefiori, D.R. Burton , J.M. Binley. A Comparative Immunogenicity Study of HIV-1 Virus-Like Particles Bearing Various Forms of Envelope Proteins, Particles Bearing no Envelope and soluble monomeric gp120.   Virology, 366 :245-262, 2007. [PubMed Abstract]

Braciale, T.J., Y.S. Hahn and D.R. Burton . Adaptive immune responses to viral infection.   In:   Fields Virology , (D.M. Knipe and P.M. Howley, Eds) Fifth Edition, Lippincott, pp. 279-325, 2007. [PubMed Abstract]

Law, M., R.M.F. Cardoso, I.A. Wilson, D.R. Burton . Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy. J. Virol., 81: 4272-4285, 2007. [PubMed Abstract]

Oswald W.B., T.W. Geisbert, K.J. Davis, J.B. Geisbert, N.J. Sullivan, P.B. Jahrling, P.W.H.I. Parren, D.R. Burton .   Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys, PLoS Pathogens , 3 :62-66 2007. [PubMed Abstract]

Bowley, D.R., A.F. Labrijn, M.B. Zwick, D.R. Burton . Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage, Protein Engineering Design & Selection (PEDS) , 20: 81-90, 2007. [PubMed Abstract]

Scanlan, C.N., G.E. Ritchie, K. Baruah, D. Harvey, B.B. Singer, L. Lucka, M.D. Crispin, M.R. Wormald, P. Wentworth, Jr., N. Zitzmann, P.M. Rudd, D.R. Burton , R.A. Dwek.   Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralizing, HIV-1 specific antibody.   J. Mol. Biol. , 372 :16-22, 2007. [PubMed Abstract]

Mantis, N.J., A.J. Hessell, J. Palaia, S. Mahta, Z. Zhu, B. Corthesy, M.R. Neutra, D.R. Burton , E.N. Janoff.   Inhibition of HIV-1 infectivity and epithelial cell transfer by a recombinant human IgA to envelope gp120.   J. Immunology, 179: 3144-315 2 , 2007. [PubMed Abstract]

Hessell, A.J., L. Hangartner, M. Hunter, C.E.G. Havenith, F.J. Beurskens, J.M. Bakker, C.M.S. Lanigan, G. Landucci, D.N. Fothal, P.W.H.I. Parren, P.A. Marx, D.R. Burton .   The Fc receptor but not complement binding is important in antibody protection against HIV.   Nature , 449: 101-104, 2007. [PubMed Abstract]

Scherer, E.M., M.B. Zwick, L. Teyton, D.R. Burton . Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity. AIDS , 21 :2131-2139, 2007. [PubMed Abstract]

Burton, D.R. , I.A. Wilson.   Square dancing antibodies.   Science , 317: 1507-1508, 2007. [PubMed Abstract]

Law, M., T. Maruyama, J. Lewis, E. Giang, A.W. Tarr, Z. Stamataki, P. Gastaminza, F.V. Chisari, I.M. Jones, R.I. Fox, J.K. Ball, J.A. McKeating, N.M. Kneteman, D.R. Burton .   Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge.   Nature Medicine, 14: 26-27, 2007. [PubMed Abstract]

Zwick, M.B., Burton, D.R.   HIV-1 neutralization:   mechanisms and relevance to vaccine design.   Current HIV Research , 5 :608-624, 2007. [PubMed Abstract]

Koff, W.C., P.R. Johnson, D.I. Watkins, D.R. Burton , J.D. Lifson, K. Hasenkrug, A.B. McDermott, A. Schultz, T.J. Zamb, R. Boyle and R.C. Desrosiers.   HIV vaccine design:   Insights from live attenuated SIV vaccines. Nature Immunology , 7 :19-23, 2006. [PubMed Abstract]

Burton, D.R.   Images from the surface of HIV.   Nature , 441:817-818, 2006. [PubMed Abstract]

Burton, D.R. and R.A. Dwek. Sugar determines antibody activity.   Science , 313:627-628, 2006. [PubMed Abstract]

Delves, P.J., S.J. Martin, D.R. Burton , I.M. Roitt, Roitt's Essential Immunology, 11 th Edition, Blackwell Publishing, Oxford, U.K., In Press, 2006

Pantophlet, R., D.R. Burton .   gp120:   Target for neutralizing HIV-1 antibodies, Ann. Rev. of Immunol., 24 :739-769, 2006. [PubMed Abstract]

Law, M., P.P. Sanna, and D.R. Burton. Viral Subversion of Humoral Immune Responses.  In   Microbial Subversion of Immmunity: Current Topics ,   (P. J. Lachmann and M. B. A. Oldstone, Editors)  Caister Academic Press, Norfolk, UK, pp. 177-210, 2006.

Calarese, D., C. Scanlan, H-K. Lee, P. Rudd, C-H. Wong, R.A. Dwek, D.R. Burton , I. A. Wilson.   Towards a carbohydrate-based HIV-1 vaccine.   Carbohydrate Drug Design, American Chemical Society Symposium Series, Oxford University Press, Oxford, UK, 2006.

Koff, W.C., P.R. Johnson, D.I. Watkins, D.R. Burton , J.D. Lifson, K. Hasenkrug, A.B. McDermott, A. Schultz, T.J. Zamb, R. Boyle and R.C. Desrosiers.   HIV vaccine design:   Insights from live attenuated SIV vaccines. Nat. Immunol., 7 :19-23, 2006. [PubMed Abstract]

Moore, P.L., E.T. Crooks, M.L Porter, P. Zhu, C.S. Cayanan, M.B. Zwick, C. Wiley, P. Corcoran, M. Franti, J. Lifson, L.O. Arthur, L. Morris, K.H. Roux, D.R. Burton , and J.M. Binley.   Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1.   J. Virol., 80:2515-2528, 2006. [PubMed Abstract]

Selvarajah, S. B. Puffer, F-H. Li, P. Zhu, Y Li, R. Wyatt, K. Roux, R. Doms and D.R. Burton .   Focused dampening of antibody responses to the immunodominant variable loops by engineered soluble gp140.    AIDS Research & Human Retroviruses , 24: 1-14, 2008. [PubMed Abstract]

Burton, D.R., R.L. Stanfield, I.A. Wilson.   Antibody vs. HIV in a clash of evolutionary titans, Proc. Natl. Acad. Sci. , 102: 14943-14948, 2005. [PubMed Abstract]

Lindenbach, B.D., M.J. Evans, A.J. Syder, B. Wolk, T.L. Tellinghuisen, C.C. Liu, T. Maruyama, R.O. Hynes, D.R. Burton, J.A. McKeating, C.M. Rice.   Complete replication of hepatitis C virus in cell culture.   Science , 309:623-626, 2005. [PubMed Abstract]

Cardoso, R.M.F., M.B. Zwick, R.L. Stanfield, R. Kunert, J.M. Binley, H. Katinger, D.R. Burton, I.A. Wilson.   Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41:   Implications for vaccine design.   Immunity , 22 :163-173, 2005. [PubMed Abstract]

Calarese, D. H-K. Lee, C-Y Huang, M. Best, R. Astronomo, R. Stanfield, H. Katinger, D.R. Burton , C-H Wong and I. Wilson.   Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12 by chemical synthesis and structural analysis.   Proc. Natl. Acad. Sci., 102:13372-13377 2005. [PubMed Abstract]

Zhong, J., P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D.R. Burton , S.F. Wieland, S.L. Uprichard, T. Wakita F. V. Chisari.   Robust hepatitis C virus infection in vitro.   Proc. Natl. Acad. Sci., 102 :9294-9299, 2005. [PubMed Abstract]

Zwick, M.B., R. Jensen, S. Church, M. Wang, G. Stiegler, R. Kunert, H. Katinger, D.R. Burton . The anti-human immunodeficiency virus type 1 antibodies 2F5 and 4E10 require only a surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1. J. Virol., 79 :1252-1261 , 2005. [PubMed Abstract]

Zwick, M.B., H.K. Komori, R.L. Stanfield, S. Church, M. Wang, P.W.H.I. Parren, R. Kunert, H. Katinger, I.A. Wilson and D.R. Burton .   The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-HIV-1 antibody 2F5.   J. Virol., 78: 3155-3161, 2004. [PubMed Abstract]

Burton, D.R. , R.C. Desrosiers, R.W. Doms, W.P. Koff, P.D. Kwong, J.P. Moore, G.P. Nabel, J. Sodroski, I.A. Wilson and R.P. Wyatt.   HIV vaccine design and the neutralizing antibody problem. Nature Immunology , 5 :233-236, 2004. [PubMed Abstract]

Binley, J.M., T. Wrin, B. Korber, M.B. Zwick, M. Wang, C. Chappey, G. Stiegler, R. Kunert, S. Zolla-Pazner, H. Katinger, C.J. Petropoulos, D.R. Burton .   A comprehensive cross-clade neutralization analysis of panel of anti-HIV-1 monoclonal antibodies.   J. Virol., 78: 13232-13252 , 2004. [PubMed Abstract]

Burton, D.R. , R.C. Desrosiers, R.W. Doms, M.B. Feinberg, R.C. Gallo, M. Hahn, J.A. Hoxie, E. Hunter, B. Korber, A. Landay, M.M. Lederman, J. Lieberman, J.M. McCune, J.P. Moore, N. Nathanson, L. Picker, D. Richman, C. Rinaldo, M. Stevenson, D.I. Watkins, S.M. Wolinsky, J.A. Zack.   A sound rationale needed for phase III HIV-1 vaccine trials.   Science, 303 :316, 2004. [PubMed Abstract]

Pantophlet, R., I. Wilson and D.R. Burton .   Improved design of an antigen with enhanced specificity for the broadly HIV-neutralizing antibody b12. Protein Engineering, Design and Selection , 17: 749-758, 2004. [PubMed Abstract]

Moore, J.P., D.R. Burton .   Urgently needed:   a flter for the HIV-1 vaccine pipeline.   Nature Medicine, 10: 769-771, 2004. [PubMed Abstract]

Zwick, M.B., R.A. Williamson, D.R. Burton .   Combinatorial phage antibody libraries.     Encyclopedia of Molecular Cell Biology & Molecular Medicine (R.A. Meyers, Editor) Wiley-VCH Verlag, Weinheim, Germany, Vol. 3, pp. 75-99, 2004.

Zwick, M.B., E.O. Saphire and D.R. Burton .   gp41:   The shy protein of HIV.   Nature Medicine , 10:133-134, 2004. [PubMed Abstract]

Woof, J.M., D.R. Burton .   Human antibody-Fc receptor interactions illuminated by crystal structures, Nat. Rev. Immunol., 4:89-99, 2004. [PubMed Abstract]

Pantophlet, R., I. A. Wilson and D.R. Burton .   Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design. J. Virol., 77 :5889-5901, 2003. [PubMed Abstract]

Calarese, D.A., C.N. Scanlan, M.B. Zwick, S. Deechongkit, Y. Mimura, R. Kunert, P. Zhu, M.R. Wormald, R.L. Stanfield, K.H. Roux, J.W. Kelly, P.M. Rudd, R.A. Dwek, H. Katinger, D.R. Burton * and I.A. Wilson*.   Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science , 300 :2065-2071, 2003. [PubMed Abstract]

Pantophlet, R., D.R. Burton .   Immunofocusing:   antigen engineering to promote the induction of HIV-neutralizing antibodies.   Trends in Molecular Medicine, 9:468-473, 2003. [PubMed Abstract]

Binley, J.M., C.S Cayanan, C. Wiley, N. Schulke, W.C. Olson and D.R. Burton .   Redox-triggered Infection by disulfide-shackled HIV-1 pseudovirions. J. Virol. , 77 :5678-5684, 2003. [PubMed Abstract]

Poignard*, P., M. Moulard, E. Golez, V. Vivona, M. Franti, S. Venturini, M. Wang, P.W.H.I. Parren and D.R. Burton *.   Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies.   J. Virol., 77: 353-365, 2003. [PubMed Abstract]

Labrijn, A.F., P. Poignard, A. Raja, M.B. Zwick, K. Delgado, M. Franti, J. Binley, V. Vivona, C. Grundner, C-C. Huang, M. Venturi, C.J. Petropoulos, T. Wrin, D.S. Dimitrov, J. Robinson, P. Kwong, R.T. Wyatt, J. Sodroski and D.R. Burton. Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary HIV-1. J. Virol ., 77:10557-10565, 2003. [PubMed Abstract]

Burton, D.R. Antibodies, viruses and vaccines. Nature Reviews, Immunology. 2:706-713, 2002. [PubMed Abstract]

Scanlan, C.N. R. Pantophlet, M.R. Wormald, E.O. Saphire, R. Stanfield, I.A. Wilson, H. Katinger, R.A. Dwek, P.M. Rudd and D.R. Burton, The broadly neutralizing anti-HIV-1 antibody 2G12 recognizes a cluster of a1Æ2 mannose residues on the outer face of GP120, J. Virol., 76:7306-7321, 2002. [PubMed Abstract]

Parren, P.W.H.I., T.W. Geisbert, T. Maruyama, P.B. Jahrling and D. R. Burton. Pre and Post-Exposure Prophylaxis of Ebola Virus Infection in an Animal Model by Passive Transfer of a Neutralizing Human Antibody. J. Virol., 76:6408-6412, 2002. [PubMed Abstract]

Binley, J.M., R.W. Sanders, A. Master, C.S. Cayanan, C.L. Wiley, L. Schiffner, B. Travis, S. Kuhmann, D.R. Burton, S-L. Hu, W.C. Olson, J.P. Moore. Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol., 76:2606-2616, 2002. [PubMedAbstract]

E.O. Saphire, R.L. Stanfield, M.D.M. Crispin, P.W.H.I. Parren, P.M. Rudd,R.A. Dwek, D.R. Burton and I.A. Wilson. Contrasting IgG StructuresReveal Extreme Asymmetry and Flexibility. J. Mol. Biol., 319:9-18, 2002. [PubMed Abstract]

Schaller, M., D.R. Burton, H.J. Ditzel. Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease. Nat. Immunol. 2:746-753, 2001. [PubMed Abstract]

Peretz, D., R.A. Williamson, K. Kaneko, J. Vergara, E. Leclerc, I.R. Mehlhorn, G. Legname, M.R. Wormald, P.M. Rudd, D.R. Burton and S.B. Prusiner. Antibodies inhibit prion propagation and promote clearance of infectivity from cell culture. Nature, 412:739-743, 2001. [PubMed Abstract]

Burton, D.R.   Antibodies in Viral Infection, Current Topics in Microbiology and Immunology Series, 2001.

Saphire, E.O., P.W.H.I. Parren, R. Pantophlet, M.B. Zwick, P. Rudd, R. Dwek, D.R. Burton and I. A. Wilson. Crystal structure of an intact human IgG with potent and broad activity against primary HIV-1 isolates: A template for HIV vaccine design. Science, 293:1155-1159, 2001. [PubMed Abstract]

Parren, P.W.H.I., P. Marx, A.J. Hessell, A. Luckay, J. Harouse, C. Cheng-Mayer, J.P. Moore and D.R. Burton. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J. Virology, 75:8340-8347, 2001. [PubMed Abstract]

Moore, J.P., P.W.H.I. Parren, and D.R. Burton. Genetic subtypes, humoral immunity and HIV-1 vaccine development. J. Virology, 75:5721-5729, 2001. [PubMed Abstract]

Poignard, P., E. Ollmann Saphire, P.W.H.I. Parren and D.R. Burton. gp120: Biologic aspects of structural features, Annual Reviews of Immunology, 19: 253-274, 2001. [PubMed Abstract]

Parren, W.H.I, D.R. Burton, The anti-viral activity of antibodies in vitro and in vivo. Advances in Immunology, 77:195-262, 2001. [PubMed Abstract]

Zwick, M.B., A.F. Labrijn, M. Wang, C. Spenlehauer, E.O. Saphire, J.M. Binley, J.P. Moore, G.Stiegler, H. Katinger, D.R. Burton * and P.W.H.I. Parren*.   Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.   J. Virol., 75: 10892-10905, 2001. [PubMed Abstract]

Barbas, C.F. (III), D.R. Burton , J.K. Scott, G.J. Silverman.   Phage Display.   A Laboratory Manual , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 2001.

Burton, D.R., P.W.H.I. Parren. Fighting the Ebola virus, Nature, News and Views, 408:527-528, 2000. [PubMed Abstract]

Wang, H., M. N. Griffiths, D.R. Burton and P. Ghazal, Rapid antibody responses by low dose single-step dendritic cell-targeted immunization. Proc. Natl. Acad. Sci. USA, 96, 847-852, 2000. [PubMed Abstract]

Burton, D.R. and P.W.H.I. Parren, Vaccines and the induction of functional antibodies: Time to look beyond the molecules of natural infection? Nature Medicine, 6, 123-125, 2000. [PubMed Abstract]

Parren, P.W.H.I., P. Poignard, H.J. Ditzel, R.A. Williamson and D.R. Burton, Antibodies in human infectious disease. Immunologic Research, 21, 265-278, 2000. [PubMed Abstract]

Poignard, P., R. Sabbe, G.R. Picchio, M. Wang, R. J. Gulizia, H. Katinger, P.W.H.I. Parren, D.E. Mosier, D.R. Burton, Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo, Immunity, 10:1-20, 1999. [PubMed Abstract]

Williamson, R.A. D. Peretz, C. Pinilla, H. Ball, R. B. Bastidas, R. Rozenshteyn, R. A. Houghten, S. B. Prusiner and D. R. Burton. Mapping the prion protein using recombinant antibodies. J. Virol., 72: 9413-9418, 1998. [PubMed Abstract]

Burton, D.R.   Immunoglobulin, functions.   Encyclopedia of Immunology , Academic Press, (2 nd edition) P. J. Delves and I. M. Roitt, eds., pp. 1315-1319, 1998.

Parren, P.W.H.I., Q. J. Sattentau and D.R. Burton .   HIV-1 Antibody - debris or virion? Nat. Med. , 3 :366-367, 1997. [PubMed Abstract]

Burton, D.R. A vaccine for human immunodeficiency virus type1: The antibody perspective. Proc. Natl. Acad. Sci. USA, 94:10018-10023, 1997. [PubMed Abstract]

Burton, D.R. and D.C. Montefiori. The antibody response in HIV-1 infection. AIDS, 11(suppl A) S87-S98, 1997. [PubMed Abstract]

Parren, P.W.H.I., Q. J. Sattentau and D.R. Burton. HIV-1 Antibody - debris or virion? Nature Medicine, 3:366-367, 1997. [PubMed Abstract]

Binley, J.M., H.J. Ditzel, C.F. Barbas III, N. Sullivan, J. Sodroski, P.W.H.I. Parren and D.R. Burton. Human antibody responses to HIV-1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen binding. AIDS Research and Human Retroviruses, 12:911-924, 1996. [PubMed Abstract]

Williamson, R.A., D. Peretz, N. Smorodinsky, R. Bastidas, T. Blochberger, A. Serban, S. DeArmond, S.B. Prusiner and D.R. Burton. Circumventing tolerance in order to generate autologous monoclonal antibodies to the prion protein. Proc. Natl. Acad. Sci. USA, 93:7279-7282, 1996. [PubMed Abstract]

Williamson, R.A. and D.R. Burton .   Combinatorial phage antibody libraries.   In: Molecular biology and biotechnology: A comprehensive desk reference , R.A. Myers, (ed.).   VCH Publishers, Germany, pp. 190-194, 1995.

Burton, D.R. Phage display. Immunotechnology, 1:87-94, 1995. [PubMed Abstract]

Sanna, P.P., R.A. Williamson, A. De Logu, F.E. Bloom and D.R. Burton. Directed selection of recombinant human monoclonal antibodies to HSV glycoproteins from phage display libraries. Proc. Natl. Acad. Sci. USA, 92:6439-6443, 1995. [PubMed Abstract]

Barbas, S.M., H.J. Ditzel, E.M. Salonen, W.P. Yang, G.J. Silverman and D.R. Burton. Human autoantibody recognition of DNA. Proc. Natl. Acad. Sci. USA, 92: 2529-2533, 1995. [PubMed Abstract]

Burton, D.R. * J. Pyati, R. Koduri, S.J. Sharp, G.B. Thornton, P.W.H.I. Parren, L.S.W. Sawyer, R.M. Hendry, N. Dunlop, P.L. Nara, M. Lamacchia, E. Garratty, E.R. Stiehm, Y.J. Bryson, Y. Cao, J.P. Moore, D.D. Ho and C.F. Barbas III*.   Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody.   Science , 266 :1024-1027, 1994. [PubMed Abstract]

Burton, D.R. , and C.F. Barbas III.   Human antibodies from combinatorial libraries.   Adv. Immunol., 57 :191-280, 1994. [PubMed Abstract]

Burton, D.R.   The structure of immunoglobulins and their interaction with complement. In: Activators and Inhibitors of Complement , R.B. Sim (ed.).   The Netherlands: Kluwer Academic Publishers, pp. 17-36, 1993.

Burton, D.R. , and C.F. Barbas III.   Antibodies from libraries.   Nature , 359 :782-783, 1992. [PubMed Abstract]

Burton, D.R.   The conformation of antibodies.   In : Fc receptors and the action of antibodies , H. Metzger (ed.).   Washington, D.C.: American Society of Microbiology series, pp. 31-54, 1990.